Clinical Trial Update: Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed sirolimus for poor prognosis Immunoglobulin A nephropathy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin Nephropathy

Drugs mentioned

• Rapamune (sirolimus) (sirolimus)

Snippet

Sponsor: Josep m Cruzado | Conditions: Glomerulonephritis, IGA, Nephropathy, IGA | Phase 2 | Status: COMPLETED